149 related articles for article (PubMed ID: 4704105)
1. Effective treatment of Kaposi's sarcoma with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
Vogel CL; Primack A; Owor R; Kyalwazi SK
Cancer Chemother Rep; 1973 Feb; 57(1):65-71. PubMed ID: 4704105
[No Abstract] [Full Text] [Related]
2. Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.
Einhorn LH; McBride CM; Luce JK; Caoili E; Gottlieb JA
Cancer; 1973 Oct; 32(4):749-55. PubMed ID: 4751911
[No Abstract] [Full Text] [Related]
3. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.
Frei E; Luce JK; Talley RW; Vaitkevicius VK; Wilson HE
Cancer Chemother Rep; 1972 Oct; 56(5):667-70. PubMed ID: 4569060
[No Abstract] [Full Text] [Related]
4. Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.
Gerner RE; Moore GE; Didolkar MS
Cancer; 1973 Oct; 32(4):756-60. PubMed ID: 4751912
[No Abstract] [Full Text] [Related]
5. Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
Gams RA; Carpenter JT
Cancer Chemother Rep; 1974; 58(5 Pt 1):753-4. PubMed ID: 4214608
[No Abstract] [Full Text] [Related]
6. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].
Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U
Tumori; 1973; 59(3):239-48. PubMed ID: 4729646
[No Abstract] [Full Text] [Related]
7. Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.
Gerner RE; Moore GE
Cancer Chemother Rep; 1973 Feb; 57(1):83-4. PubMed ID: 4704107
[No Abstract] [Full Text] [Related]
8. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.
Finklestein JZ; Albo V; Ertel I; Karon M; Hammond D
Cancer Chemother Rep; 1972 Aug; 56(4):523-6. PubMed ID: 4507686
[No Abstract] [Full Text] [Related]
9. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
Falkson G; Van der Merwe AM; Falkson HC
Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061
[No Abstract] [Full Text] [Related]
10. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
Carter SK; Friedman MA
Eur J Cancer (1965); 1972 Feb; 8(1):85-92. PubMed ID: 4552317
[No Abstract] [Full Text] [Related]
11. Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).
Luce JK; Thurman WG; Isaacs BL; Talley RW
Cancer Chemother Rep; 1970 Apr; 54(2):119-24. PubMed ID: 4334086
[No Abstract] [Full Text] [Related]
12. Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide.
Gottlieb JA; Baker LH; Quagliana JM; Luce JK; Whitecar JP; Sinkovics JG; Rivkin SE; Brownlee R; Frei E
Cancer; 1972 Dec; 30(6):1632-8. PubMed ID: 4663966
[No Abstract] [Full Text] [Related]
13. Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.
Stolinsky DC; Bogdon DL; Solomon J; Bateman JR
Cancer; 1972 Sep; 30(3):654-9. PubMed ID: 5075351
[No Abstract] [Full Text] [Related]
14. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.
Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ
Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016
[No Abstract] [Full Text] [Related]
15. Treatment of Kaposi's sarcoma by combination of actinomycin-D, vincristine and imidazole carboxamide (nsc-45388): results of a randomized clinical trial.
Olweny CL; Toya T; Mbidde EK; Lwanga SK
Int J Cancer; 1974 Nov; 14(5):649-56. PubMed ID: 4617713
[No Abstract] [Full Text] [Related]
16. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
Ahmann DL; Hahn RG; Bisel HF
Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
[No Abstract] [Full Text] [Related]
17. 5-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in the treatment of childhood malignancy.
Komp DM; Land VJ; Nitschke R; Cangir A; Dyment P
Cancer Chemother Rep; 1975; 59(2 Pt 1):371-6. PubMed ID: 1097094
[No Abstract] [Full Text] [Related]
18. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer.
Falkson G; van Eden EB; Falkson HC
Cancer; 1974 May; 33(5):1207-9. PubMed ID: 4595974
[No Abstract] [Full Text] [Related]
19. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
Gutterman JU; Mavligit G; Gottlieb JA; Burgess MA; McBride CE; Einhorn L; Freireich EJ; Hersh EM
N Engl J Med; 1974 Sep; 291(12):592-7. PubMed ID: 4851001
[No Abstract] [Full Text] [Related]
20. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
Kline I; Woodman RJ; Gang M; Cysyk RL; Venditti JM
Cancer Chemother Rep; 1973; 57(3):291-8. PubMed ID: 4751255
[No Abstract] [Full Text] [Related]
[Next] [New Search]
